NJ

Nirav Jitendrabhai Rathod

Active Director Additional Director DIN 11499166
DIN 11499166 First appointment Jan 2026 Primary industry Ecommerce and Internet
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Nirav Jitendrabhai Rathod

Data last updated:

Nirav Jitendrabhai Rathod is an Additional Director at Indoclin Private Limited (since 2026). The company operates in Ecommerce and Internet.

DIN 11499166
Primary Designation Additional Director
Industry Ecommerce and Internet
First Appointment 22 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Indoclin Private Limited U47190PN2023PTC226816
Additional Director22 Jan 2026Active

Board colleagues of Nirav Jitendrabhai Rathod

NameDINCompanyDesignation
Suraj Barkatali Punjani10444804Indoclin Private LimitedDirector

Directorship timeline

Open interactive timeline →
Indoclin Private Limited
Premium access

Shareholding and investment profile for Nirav Jitendrabhai Rathod

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nirav Jitendrabhai Rathod

Nirav Jitendrabhai Rathod currently holds 1 directorship: Indoclin Private Limited (Additional Director, since 22 Jan 2026).

Nirav Jitendrabhai Rathod was first appointed on 22 Jan 2026 as Additional Director at Indoclin Private Limited.

The current boards of Nirav Jitendrabhai Rathod's companies include Suraj Barkatali Punjani (Indoclin Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available